| 2025 | 2023 | 2022 | 2021 | 2020 | 2018 | 2015 | 2011 | 2010 | 2009 | 2008 | 2008 | 2007 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | 5,7 M € | -3.0% | 5,9 M € | -1.5% | 6,0 M € | -10.4% | 6,7 M € | +156.1% | 2,6 M € | — | — | |||||||||
| Gross margin | 619,4 k € | -9.1% | 681,7 k € | +34.6% | 506,5 k € | -5.9% | 538,5 k € | -9.9% | 597,5 k € | +0.1% | 596,7 k € | — | — | — | — | — | -7,9 k € | — | ||||||||
| EBITDA | 196,2 k € | -40.7% | 331,2 k € | +78.0% | 186,1 k € | +85.5% | 100,3 k € | -19.1% | 124,0 k € | -35.1% | 191,1 k € | +37.8% | 138,6 k € | -36.4% | 218,0 k € | -43.0% | 382,1 k € | -48.4% | 740,6 k € | +357.1% | 162,0 k € | +2124.5% | -8,0 k € | +27.0% | -11,0 k € | |
| Operating profit | 196,3 k € | -31.3% | 285,8 k € | +56.7% | 182,4 k € | +75.9% | 103,7 k € | -15.4% | 122,5 k € | -35.4% | 189,7 k € | +43.1% | 132,6 k € | -39.4% | 218,8 k € | -42.0% | 377,1 k € | -49.1% | 741,0 k € | +393.5% | 150,2 k € | +1976.0% | -8,0 k € | +27.0% | -11,0 k € | |
| Profit/loss | 167,0 k € | -18.3% | 204,5 k € | +43.0% | 143,0 k € | +195.3% | 48,4 k € | -49.9% | 96,6 k € | -33.6% | 145,6 k € | -9.0% | 160,0 k € | -24.5% | 212,0 k € | -1.0% | 214,2 k € | -48.6% | 416,7 k € | +296.7% | 105,0 k € | +1356.4% | -8,4 k € | +24.5% | -11,1 k € | |
| Equity | 2,7 M € | +16.8% | 2,3 M € | +9.7% | 2,1 M € | +7.3% | 2,0 M € | +2.5% | 1,9 M € | +19.8% | 1,6 M € | +43.7% | 1,1 M € | -41.8% | 1,9 M € | +12.5% | 1,7 M € | +14.4% | 1,5 M € | +38.9% | 1,1 M € | +187095.5% | 572,0 € | -93.6% | 8,9 k € | |
| Total assets | 3,5 M € | +8.8% | 3,2 M € | +4.3% | 3,1 M € | +2.1% | 3,0 M € | -0.8% | 3,0 M € | +23.9% | 2,4 M € | -38.9% | 4,0 M € | +39.4% | 2,9 M € | -39.7% | 4,7 M € | +20.3% | 3,9 M € | +42.0% | 2,8 M € | +485565.7% | 572,0 € | -96.8% | 17,8 k € | |
| Cash | — | — | — | — | — | 547,2 k € | -17.2% | 660,7 k € | +461.4% | 117,7 k € | +109.0% | 56,3 k € | +521.7% | 9,1 k € | -98.4% | 582,7 k € | +102127.0% | 570,0 € | -96.3% | 15,3 k € | ||||||
| Debts | 771,6 k € | -12.2% | 878,6 k € | -7.6% | 950,8 k € | -7.8% | 1,0 M € | -5.8% | 1,1 M € | +32.7% | 825,2 k € | -71.0% | 2,8 M € | +199.7% | 949,9 k € | -68.8% | 3,0 M € | +23.9% | 2,5 M € | +44.0% | 1,7 M € | — | 8,8 k € | |||
| Staff | 3 | 3 | 2 | 3,2 | 3,9 | 3 | 4 | 9 | 8,3 | 9 | 8,6 | — | — | |||||||||||||
Private limited company · Braine-l'Alleud · incorporated on 07/06/2006 · 3,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-17.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Conva Tec Belgium is a Private limited company incorporated in 2006. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Braine-l'Alleud. It employs on average 3,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette